Dihexa is a small molecule derived from angiotensin IV, developed in the laboratory of Joseph Harding at Washington State University
Key Research Areas for the Wolverine Stack Dual-phase tissue repair pathway studies vascular/ECM organisation (BPC-157) and cellular migration/cytoskeletal reconstruction (TB-500) Musculoskeletal healing pathway research tendon, ligament, muscle, and connective tissue models Angiogenesis studies VEGF/VEGFR2 upregulation, vascular tube formation, capillary network organisation Fibroblast migration, adhesion, and ECM stabilisation assays Stem/progenitor cell mobilisation and tissue-site differentiation studies Anti-inflammatory and anti-oxidative stress pathway research TNF-, IL-6, reactive oxygen species modulation Collagen synthesis, fibre alignment, and organisational quality studies Combination vs
A systematic review published in a 2025 orthopedic sports medicine journal, covering 35 preclinical studies, confirmed that BPC-157 reduced inflammatory cytokines and improved muscle injury outcomes
ISSN 1873-0183
Hold time depends on the formulation
As you exhale, trace amounts of alcohol vapor are released, which the device detects and calculates into a BAC reading